Cell-Autonomous and Non-Cell-Autonomous Antiviral Immunity via siRNA-Directed RNAi in Drosophila melanogaster
Immune Discovery · 2025
DOI: 10.70322/immune.2025.10002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immune Discovery, 2025. Verfasst von Haojiang Luan. Die Arbeit nennt 126 Literaturangaben.
Abstract (Originalsprache)
In Drosophila melanogaster, the siRNA-directed RNAi pathway provides crucial antiviral defenses. Cell-autonomously, Dicer-2 (Dcr-2) recognizes and cleaves viral dsRNA into siRNAs, which are incorporated into the RNA-induced silencing complex (RISC). Argonaute 2 (Ago2) then targets and cleaves viral RNA, preventing replication. Non-cell-autonomously, infected hemocytes secrete exosomes containing viral siRNAs, spreading antiviral signals to other cells. Additionally, tunneling nanotubes can transfer RNAi components between neighboring cells, further enhancing systemic immunity. These findings highlight the sophisticated antiviral strategies in Drosophila, offering insights for broader antiviral research.
Zitieren
APA
Luan, H. (2025). Cell-Autonomous and Non-Cell-Autonomous Antiviral Immunity via siRNA-Directed RNAi in Drosophila melanogaster. Immune Discovery. https://doi.org/10.70322/immune.2025.10002
Vancouver
Luan H. Cell-Autonomous and Non-Cell-Autonomous Antiviral Immunity via siRNA-Directed RNAi in Drosophila melanogaster. Immune Discovery. 2025. doi:10.70322/immune.2025.10002
BibTeX
@article{Luan2025,
author = {Luan, Haojiang},
title = {Cell-Autonomous and Non-Cell-Autonomous Antiviral Immunity via siRNA-Directed RNAi in Drosophila melanogaster},
journal = {Immune Discovery},
year = {2025},
doi = {10.70322/immune.2025.10002}
}
EUVIMED